Anticoagulation and stroke . . . and other stories
BMJ 2024; 386 doi: https://doi.org/10.1136/bmj.q1930 (Published 12 September 2024) Cite this as: BMJ 2024;386:q1930
Timing of anticoagulation in stroke
Earlier this year, a large randomised controlled trial reported that early anticoagulation in people with atrial fibrillation who had sustained a stroke probably carried a small benefit over delayed anticoagulation. However, the confidence intervals around the estimated treatment effects were too wide to make definite recommendations (N Engl J Med doi:10.1056/NEJMoa2303048). A re-analysis finds that this conclusion isn’t changed when infarct size is taken into account. The important finding is that early treatment with direct acting oral anticoagulants doesn’t carry a higher risk of bleeding complications, intracranial haemorrhage, or other adverse events, even when the infarct is large (JAMA Neurol doi:10.1001/jamaneurol.2024.1450).
New treatments for dementia
Lecanemab and donanemab, both monoclonal …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.